Matches in Wikidata for { <http://www.wikidata.org/entity/Q64122299> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q64122299 description "clinical trial" @default.
- Q64122299 description "ensayu clínicu" @default.
- Q64122299 description "klinisch onderzoek" @default.
- Q64122299 description "клінічне випробування" @default.
- Q64122299 description "կլինիկական փորձարկում" @default.
- Q64122299 name "Rituximab Hyaluronidase and Combination Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda" @default.
- Q64122299 type Item @default.
- Q64122299 label "Rituximab Hyaluronidase and Combination Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda" @default.
- Q64122299 prefLabel "Rituximab Hyaluronidase and Combination Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda" @default.
- Q64122299 P1050 Q64122299-5D959D59-2F83-4EEB-A73D-31E91F28D122 @default.
- Q64122299 P1050 Q64122299-AF57DDA5-ADCC-4B0E-8CFD-5EE117080368 @default.
- Q64122299 P1132 Q64122299-861451BE-1062-41B8-96BF-0C48F39077A8 @default.
- Q64122299 P1476 Q64122299-D6250FAC-29DD-4DFC-9196-ABF443C56F8B @default.
- Q64122299 P17 Q64122299-D1D6C8B8-1928-4E14-AB46-70FB86CDE0B2 @default.
- Q64122299 P2899 Q64122299-708D4AD5-9E07-4444-9F0C-2013E66260CC @default.
- Q64122299 P3098 Q64122299-453A02AF-C553-45BB-A267-C684102569D8 @default.
- Q64122299 P31 Q64122299-FD80EFB6-DA59-4825-A61B-6999BBD66837 @default.
- Q64122299 P4844 Q64122299-44BBD32C-C154-44D7-A228-B3D1B28F657A @default.
- Q64122299 P4844 Q64122299-5AD13394-4730-4289-89BC-6B3C27450660 @default.
- Q64122299 P4844 Q64122299-6136CD38-8861-428C-8602-35C778A5EC0A @default.
- Q64122299 P4844 Q64122299-631F2A4C-FAF2-4BF4-B310-81E6CA203152 @default.
- Q64122299 P4844 Q64122299-66471227-A76B-4B3F-A8AD-B4459E5AD2E4 @default.
- Q64122299 P4844 Q64122299-77616E71-1A56-453D-A87A-FC0D43AE74F7 @default.
- Q64122299 P4844 Q64122299-E0A8437F-E273-400F-8F37-AEEEFAC3182B @default.
- Q64122299 P580 Q64122299-1346AC03-4E3D-4890-A422-12BCEB33D709 @default.
- Q64122299 P582 Q64122299-7DF791A1-7257-41E2-9258-4B0CF0322C9C @default.
- Q64122299 P6099 Q64122299-878F5901-CE4D-4CF2-9322-AB1037155C57 @default.
- Q64122299 P6153 Q64122299-2AB76B2F-0D1A-4F56-9760-2F51F3F18AC1 @default.
- Q64122299 P8363 Q64122299-2598B2E9-D984-4828-99EB-03385F8B1E35 @default.
- Q64122299 P1050 Q1016605 @default.
- Q64122299 P1050 Q208414 @default.
- Q64122299 P1132 "+40" @default.
- Q64122299 P1476 "A Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With Local Standard-of-Care Chemotherapy for the Treatment of Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma or as Monotherapy for Kaposi Sarcoma Herpesvirus Associated Multicentric Castleman Disease in Pediatrics Children, Adolescents, and Adults in Uganda" @default.
- Q64122299 P17 Q30 @default.
- Q64122299 P2899 "+2" @default.
- Q64122299 P3098 "NCT03864419" @default.
- Q64122299 P31 Q30612 @default.
- Q64122299 P4844 Q18936 @default.
- Q64122299 P4844 Q27260984 @default.
- Q64122299 P4844 Q29004943 @default.
- Q64122299 P4844 Q408524 @default.
- Q64122299 P4844 Q412323 @default.
- Q64122299 P4844 Q421193 @default.
- Q64122299 P4844 Q424972 @default.
- Q64122299 P580 "2019-07-15T00:00:00Z" @default.
- Q64122299 P582 "2023-05-04T00:00:00Z" @default.
- Q64122299 P6099 Q5452194 @default.
- Q64122299 P6153 Q219563 @default.
- Q64122299 P8363 Q78089383 @default.